4.3.1 Sintesi e raccomandazioni - Biblioteca Medica

32. Mozes B., Cohen Y.C., Olmer L., Shabtai E. Factors affecting change in quality of life
after prostatectomy for benign prostatic hypertrophy: the impact of surgical techniques.
Gertner Institute for Health Services Research, Chaim Sheba Medical Center, Tel Aviv,
Israel. J Urol 1996 Jan;155(1):191-6
33. Holtgrewe H.L, Valk W.L. Factors influencing the mortality and morbidity of transurethral
prostatectomy: a study of 2015 cases. J Urol 1962; 87: 450-4
34. Melchior J., Valk W.L., Foret J.D., Mebust W.K. Transurethral prostatectomy:
computerized analysis of 2,223 consecutive cases. J Urol 1974; 112: 634-42
35. Bruskewitz R.C., Larsen E.H., Madsen P.O., Dorflinger T. 3 year followup of urinary
symptoms after transurethral resection of the prostate J Urol 1986; 136: 613-5
36. Roos N.P., Wennberg J.E., Malenka D.J., Fisher E.S., McPherson K., Andersen T.F.,
Cohen M.M., Ramsey E. Mortality and reoperation after open and transurethral
resection of the prostate for benign prostatic hyperplasia. Department of Community
Health Sciences, University of Manitoba, Winnipeg, Canada. N Engl J Med 1989 Apr
27;320(17):1120-4
37. Doll H.A., Black N.A., McPherson K., Flood A.B., Williams G.B., Smith J.C. Mortality,
morbidity and complications following transurethral resection of the prostate for benign
prostatic hypertrophy. J Urol 1992; 147: 1566-73
38. Horninger W., Unterlechner H., Strasser H., Bartsch G. Transurethral prostatectomy:
mortality and morbidity. Prostate 1996; 28: 195-200
39. Holman C.D., Wisniewski Z.S., Semmens J.B., Rouse I.L., Bass A.J. Mortality and
prostate cancer risk in 19,598 men after surgery for benign prostatic hyperplasia.
Centre for Health Services Research, Department of Public Health, The University of
Western Australia, East Perth, Australia. BJU Int 1999 Jul;84(1):37-42
40. Soonawalla P.F., Pardanani D.S. Transurethral incision versus transurethral resection of
the prostate. A subjective and objective anlysis. BJU 1992; 70:174-7
41. Inman R.D., Hussain Z., Elves A.W.S., Hallworth M.J., Jones P.W. and Coppinger
S.W.V. A comparison of 1,5% glycine and 2,7% sorbitol-0,5% mannitol irrigants
during transurethral prostate resection J. Urol. 2001 December;166: 2216-2220.
42. Reuter M., Reuter H. J. Prevention of irrigant absorption during TURP: continous lowpressure
irrigation Int Urol Nephrol 1978; 10(4):293-300
43. Wise G.J., Gerstenfeld J.N., Brunner N., Grob D. Urinary incontinence following
prostatectomy in patients with myasthenia gravis. Br J Urol 1982 Aug;54(4):369-71
44. Jensen K.M.E., Jorgensen J.B., Morgensen P. Long term predictive role of urodynamics:
an 8 year follow - up of prostatic surgery for lower urinary tract symptoms Br J Urol
1996;78:213-218
45. Semmens J.B., Wisniewski Z.S., Bass A.J., Holman C.D., Rouse I.L. Trends in repeat
prostatectomy after surgery for benign prostate disease: application of record linkage to
healthcare outcomes. Centre for Health Services Research, Department of Public Health,
The University of Western Australia, Nedlands. BJU Int 1999 Dec;84(9):972-5
46. Sidney S., Quesenberry C.P. Jr, Sadler M.C., Cattolica E.V., Lydick E.G., Guess H.A.
Reoperation and mortality after surgical treatment of benign prostatic hypertrophy in
a large prepaid medical care program. Kaiser Permanente Medical Care Program, Division
of Research, Oakland, CA 94611. Med Care 1992 Feb;30(2):117-25
191